Literature DB >> 17510797

Chronic inflammation alters the contribution of neurokinin receptor subtypes to epithelial function in rat colon.

Caroline B Appleyard1, Marangelie Morales, Cariluz Santiago.   

Abstract

We have previously shown that neurokinin-1 (NK1) receptors predominantly mediate substance P-induced secretion of the non-inflamed rat colonic mucosa in vitro with a gradient in the magnitude of these responses. The aim of this study was to examine the effects of chronic inflammation on the contributions of different neurokinin receptor subtypes to colonic mucosal secretion. Colitis was induced by the intracolonic administration of 2,4,6-trinitrobenzene sulfonic acid in rats, reactivated 6 weeks later. Segments of proximal, mid- and distal colon were stripped of muscularis propria and mounted in Ussing chambers for measurement of short-circuit current. Use of selective agonists suggests that in the chronically inflamed rat colon NK1 receptors play a greater role in neurokinin-mediated mucosal secretion than do either NK2 or NK3. Selective antagonism implies that this is region-specific, with the inflammatory process altering the relative contribution of the neurokinin receptor subtypes within each region of the rat colon.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17510797     DOI: 10.1007/s10620-007-9847-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  47 in total

1.  A potent and selective agonist for NK-2 tachykinin receptor.

Authors:  P Rovero; V Pestellini; R Patacchini; S Giuliani; P Santicioli; C A Maggi; A Meli; A Giachetti
Journal:  Peptides       Date:  1989 May-Jun       Impact factor: 3.750

2.  Potent NK1 antagonism by SR-140333 reduces rat colonic secretory response to immunocyte activation.

Authors:  D Moriarty; N Selve; A W Baird; J Goldhill
Journal:  Am J Physiol Cell Physiol       Date:  2001-04       Impact factor: 4.249

3.  Involvement of substance P in noncholinergic excitation of rabbit colonic muscle.

Authors:  C B Koelbel; E A Mayer; J R Reeve; W J Snape; A Patel; F J Ho
Journal:  Am J Physiol       Date:  1989-01

4.  Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation.

Authors:  E Goldin; F Karmeli; Z Selinger; D Rachmilewitz
Journal:  Dig Dis Sci       Date:  1989-05       Impact factor: 3.199

Review 5.  SR 48968, a neurokinin A (NK2) receptor antagonist.

Authors:  X Emonds-Alt; C Advenier; T Croci; L Manara; G Neliat; M Poncelet; V Proietto; V Santucci; P Soubrié; D Van Broeck
Journal:  Regul Pept       Date:  1993-07-02

6.  SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor.

Authors:  X Emonds-Alt; D Bichon; J P Ducoux; M Heaulme; B Miloux; M Poncelet; V Proietto; D Van Broeck; P Vilain; G Neliat
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

7.  Metalloproteinases and transforming growth factor-alpha mediate substance P-induced mitogen-activated protein kinase activation and proliferation in human colonocytes.

Authors:  Hon-Wai Koon; Dezheng Zhao; Xi Na; Mary P Moyer; Charalabos Pothoulakis
Journal:  J Biol Chem       Date:  2004-08-19       Impact factor: 5.157

8.  Substance P regulates Th1-type colitis in IL-10 knockout mice.

Authors:  Joel V Weinstock; Arthur Blum; Ahmed Metwali; David Elliott; Nigel Bunnett; Razvan Arsenescu
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

9.  Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs.

Authors:  C B Appleyard; J L Wallace
Journal:  Am J Physiol       Date:  1995-07

10.  Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases.

Authors:  T R Koch; J A Carney; V L Go
Journal:  Dig Dis Sci       Date:  1987-04       Impact factor: 3.199

View more
  2 in total

1.  Effect of a neurokinin-1 receptor antagonist in a rat model of colitis-associated colon cancer.

Authors:  Beatriz Pagán; Angel A Isidro; Domenico Coppola; Zhengming Chen; Yuan Ren; Jie Wu; Caroline B Appleyard
Journal:  Anticancer Res       Date:  2010-09       Impact factor: 2.480

2.  Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer.

Authors:  Caroline B Appleyard; Myrella L Cruz; Angel A Isidro; Janelle C Arthur; Christian Jobin; Claudio De Simone
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-09-08       Impact factor: 4.052

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.